Uniparts India First Quarter 2026 Earnings: EPS: ₹7.64 (vs ₹5.52 in 1Q 2025)
Uniparts India (NSE:UNIPARTS) First Quarter 2026 Results
Key Financial Results
- Revenue: ₹2.79b (up 6.9% from 1Q 2025).
- Net income: ₹344.6m (up 39% from 1Q 2025).
- Profit margin: 12% (up from 9.5% in 1Q 2025). The increase in margin was driven by higher revenue.
- EPS: ₹7.64 (up from ₹5.52 in 1Q 2025).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Uniparts India shares are down 2.8% from a week ago.
Risk Analysis
We should say that we've discovered 2 warning signs for Uniparts India (1 shouldn't be ignored!) that you should be aware of before investing here.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:UNIPARTS
Uniparts India
Manufactures and sells engineering systems, solutions, and assemblies primarily for off-highway vehicles in India, the United States, the Asia Pacific, Europe, Japan, and internationally.
Flawless balance sheet with proven track record and pays a dividend.
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives

Baviera: A 40% ROCE Compounding Machine Trading at Distressed Multiples — Fair Value €88/share

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

A company I wrote off that quietly turned itself around
Popular Narratives

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Investment Analysis (May 2026)
